Abstract:Background: Osteosarcoma (OS) is the leading cancer-associated mortality in childhood and adolescence. Increasing evidence has demonstrated the key function of microRNAs (miRNAs) in OS development and chemoresistance. Among them, miRNA-605-3p acted as an important tumor suppressor and was frequently down-regulated in multiple cancers. However, the function of miR-650-3p in OS has not been reported. Objective: The aim of this work is to explore the novel role of miR-605-3p in osteosarcoma and its possible involvement in OS chemotherapy resistance. Method: The expression levels of miR-605-3p in OS tissues and cells were assessed by reverse transcription quantitative PCR (RT-qPCR). The relevance of miR-605-3p with the prognosis of OS patients was determined by the Kaplan-Meier analysis. Additionally, the influence of miR-605-3p on OS cell growth was analyzed using the cell counting kit-8, colony formation assay, and flow cytometry. The mRNA and protein expression of RAF1 were detected by RT-qPCR and western blot. The binding of miR-605-3p with the 3'-UTR of RAF1 was confirmed by dual-luciferase reporter assay. Results: Our results showed that miR-605-3p was markedly decreased in OS tissues and cells. A lower level of miR-605-3p was strongly correlated with lymph node metastasis and poor 5-year overall survival rate of OS patients. In vitro assay found that miR-605-3p suppressed OS cell proliferation and promoted cell apoptosis. Mechanistically, the proto-oncogene RAF1 was seen as a target of miR-605-3p and strongly suppressed by miR-605-3p in OS cells. Restoration of RAF1 markedly eliminated the inhibitory effect of miR-605-3p on OS progression, suggesting RAF1 as a key mediator of miR-605-3p. Consistent with the decreased level of RAF1, miR-605-3p suppressed the activation of both MEK and ERK in OS cells, which are the targets of RAF1. Moreover, lower levels of miR-605-3p were found in chemoresistant OS patients, and downregulated miR-605-3p increased the resistance of OS cells to therapeutic agents. Conclusion: Our data revealed that miR-605-3p serves as a tumor suppressor gene by regulating RAF1 and increasing the chemosensitivity of OS cells, which provided the novel working mechanism of miR-605-3p in OS. Engineering stable nanovesicles that could efficiently deliver miR-605-3p with therapeutic activity into tumors could be a promising therapeutic approach for the treatment of OS.

Abstract 1482: Triptolide Inhibits the Growth of Osteosarcoma by Regulating Microrna-181A Via Targeting PTEN Gene in Vivo and in Vitro

Triptolide Inhibits the Growth of Osteosarcoma by Regulating Microrna-181A Via Targeting PTEN Gene in Vivo and Vitro.

MicroRNA-211 inhibits tumor growth and invasion through directly targeting RUNX 2 in osteosarcoma

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS

Triptolide Induces Mitochondrial Apoptosis Through Modulating Dual Specificity Phosphatase 1/Mitogen-Activated Protein Kinases Cascade in Osteosarcoma Cells

Circ_0051079 Silencing Inhibits the Malignant Phenotypes of Osteosarcoma Cells by the TRIM66/Wnt/β-catenin Pathway in a Mir-625-5p-dependent Manner

[Effect of Triptolide on Human Oral Cancer Cell Proliferation and PTEN Gene Mrna Expression in Oral Cancer].

AMD3100 Combined with Triptolide Inhibit Proliferation, Invasion and Metastasis and Induce Apoptosis of Human U2OS Osteosarcoma Cells.

Triptolide Prevents Bone Loss Via Suppressing Osteoclastogenesis Through Inhibiting PI3K‐AKT‐NFATc1 Pathway

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-618 Directly Targets Metadherin Mrna to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output

Triptonide Modulates MAPK Signaling Pathways and Exerts Anticancer Effects via ER Stress-Mediated Apoptosis Induction in Human Osteosarcoma Cells

Mir-92A Promotes Tumor Growth of Osteosarcoma by Targeting PTEN/AKT Signaling Pathway.

Knockdown of Microrna-181A Inhibits Osteosarcoma Cells Growth and Invasion Through Triggering NLRP3-dependent Pyroptosis.

Increased Accumulation of Hypoxia-Inducible Factor-1Α with Reduced Transcriptional Activity Mediates the Antitumor Effect of Triptolide.

miRNA‐216 knockdown has effects to suppress osteosarcoma via stimulating PTEN

Network pharmacology and experiment validation investigate the potential mechanism of triptolide in oral squamous cell carcinoma

Expression and Regulatory Effects of Microrna-182 in Osteosarcoma Cells: A Pilot Study

MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1

Trifluoperazine exerts anti-osteosarcoma effect by inducing mitochondria-dependent apoptosis via AKT/TXNIP signaling pathway